Do you want to read an article? Please log in or register.
Endoscopic Valve Removal >180 Days since Implantation in Patients with Severe Emphysema
Related content
RECOMMENDED
Emphysema
Long-term follow up after endoscopic valve therapy in patients with severe emphysema
Ther Adv Respir Dis.
Gompelmann D, Heinhold T, Rötting M, Bischoff E, Kontogianni K, Eberhardt R, Herth FJF
doi: 10.1177/1753466619866101.
RECOMMENDED
Emphysema
Lung volume reduction with endobronchial valves in patients with emphysema
Expert Rev Med Devices.
Van Der Molen MC, Klooster K, Hartman JE, Slebos DJ
doi: 10.1080/17434440.
RECOMMENDED
Emphysema
Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema
Curr Med Res Opin.
Evans R, Brutsche M, Busca R, Deslee G, de Soyza A, Fellrath JM, Franzen D, Hartman J, Mealing S, Morton T, Munavvar M, Sculpher M, Shah PL, Slebos DJ, Durand-Zaleski I
doi: 10.1080/03007995.
RECOMMENDED
Emphysema
Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis
Lancet Respir Med.
van Geffen WH, Slebos DJ, Herth FJ, Kemp SV, Weder W, Shah PL
doi: 10.1016/S2213-2600(18)30431-4.
RECOMMENDED
Asthma
A Charter to Improve Patient Care in Severe Asthma
doi: 10.1007/s12325-018-0777-y.
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial.
Lancet Respir Med.
Herth FJ, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, McNulty WH, Petermann C, Snell G, Gompelmann D
doi: 10.1016/
RECOMMENDED
Emphysema
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration® Valve System (EMPROVE): A Multicenter, Open-Label, Randomized, Controlled Trial
Am J Respir Crit Care Med.
Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S, EMPROVE Study Group.
doi: 10.1164/rccm.201902-0383OC.
COMMENTED
COPD
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)
Am J Respir Crit Care Med.
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group
doi: 10.1164/rccm.
RECOMMENDED
Respiratory Tract Infection
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
★ 3
Recommended by
Dr Martin Frey, Faculty Member
N Engl J Med.
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A, GS-US-540-5773 Investigators.
doi: 10.1056/NEJMoa2015301.